CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Potential Benefit in Preventing Acute GVHD at the 62nd American Society of Hematology MeetingPRNewsWire • 12/06/20
CTI BioPharma Announces Publication of Article Highlighting Pacritinib Data from the PAC203 Phase 2 Study in Myelofibrosis in Blood AdvancesPRNewsWire • 11/30/20
CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology MeetingPRNewsWire • 11/04/20
CTI BioPharma to Report Third Quarter 2020 Financial Results on November 10, 2020PRNewsWire • 11/02/20
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)Insider Monkey • 10/26/20
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical TrialPRNewsWire • 06/01/20
CTI BioPharma to Present at the Jefferies 2020 Healthcare Conference on Thursday, Jun. 4PRNewsWire • 05/28/20
CTI Biopharma Accelerated Review, And Other News: The Good, Bad, And Ugly Of BiopharmaSeeking Alpha • 02/11/20